NCT07157007Phase 2Completed

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Study sponsor: Traws Pharma, Inc. · TRAW

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02-16Actual
Enrollment · participants93Actual
Source updated2026-11-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 90 participants (planned). After: 93 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Feb 2026. After: 16 Feb 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

· 1 field changed

Primary completion date changed

Before: Dec 2025. After: Feb 2026.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source